← boothcheck All Stocks

AMRZ

Amrize Ltd

In the published model solve dated 2026-Q2, anchored at $43.82, Amrize Ltd (AMRZ) is priced for +20.6% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.

Published model solve
+20.6% growth
Priced In
unavailable

Key Takeaways

• Barely a year removed from Holcim, Amrize is still describing itself in the past tense of a carve-out, and the annual report says so directly: ⟦We have limited operating history as a standalone company⟧. • Aggregates and other construction materials is the largest line at 39% of revenue, with cement close behind at 37% and the roofing-and-insulation Building Envelope segment at 28%, which makes this both a quarry business and a building-products business in one wrapper. • Second quarter result

View Full Report →

Is AMRZ overvalued? See what's priced in →

Institutional ownership

435 institutional managers reported holding AMRZ in 13F filings for the quarter ended 2026-03-31. Together they hold about 43% of the company; the top 10 hold 21%. 98 opened new positions that quarter. Held by Vanguard Group, BlackRock, UBS, among others. On the short side, 8.4M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.5 days of typical volume to cover).

Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.

Insider activity

Open-market insider buys at AMRZ over the trailing three years: 2025: 56 buys totaling $60.28M; 2026: 15 buys totaling $5.88M. 19 officers and directors are on file.

Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.

Earnings reactions

AMRZ's recent reports: the day-one move, then what the following quarter actually did.

reportday onenext quarter
2025-10-30+6.0%+4.0%
2026-02-19+8.3%-11.0%
2026-05-08-6.5%pending

Day-one is the close-to-close move around the filing. Nothing here is investment advice.

Recent filings

AMRZ's latest 8-K filings: 2026-09-01 (items 5.02); 2026-08-24 (items 5.02, 7.01, 9.01); 2026-08-06 (items 2.02, 7.01, 9.01); 2026-04-29 (items 2.02, 7.01); 2026-04-21 (items 5.07, 8.01, 9.01).

Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.

Compare AMRZ

AMRZ vs CXAMRZ vs EXPAMRZ vs OCAMRZ vs TGLS

Model solve date: 2026-Q2
Narrative composed: July 25, 2026

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.